Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (SHE:301126) — Market Cap & Net Worth
Market Cap & Net Worth: Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (301126)
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd (SHE:301126) has a market capitalization of $285.54 Million (CN¥1.95 Billion) as of June 17, 2026. Listed on the SHE stock exchange, this China-based company holds position #15206 globally and #4512 in its home market, demonstrating a -1.96% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's stock price CN¥9.50 by its total outstanding shares 205403200 (205.40 Million). Review 301126 total liabilities to assess the company's total debt and financial obligations.
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Market Cap History: 2021 to 2026
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's market capitalization history from 2021 to 2026. Data shows change from $676.38 Million to $285.54 Million (-18.14% CAGR).
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.07x
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's market cap is 0.07 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $676.38 Million | $2.59 Billion | $68.26 Million | 0.26x | 9.91x |
| 2022 | $444.76 Million | $3.29 Billion | $51.08 Million | 0.14x | 8.71x |
| 2023 | $390.03 Million | $3.90 Billion | $34.30 Million | 0.10x | 11.37x |
| 2024 | $313.79 Million | $5.23 Billion | $26.57 Million | 0.06x | 11.81x |
| 2025 | $369.40 Million | $5.14 Billion | -$242.46 Million | 0.07x | N/A |
Competitor Companies of 301126 by Market Capitalization
Companies near Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd in the global market cap rankings as of June 17, 2026.
Key companies related to Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd by market ranking:
- JD HEALTH INTL LTD (F:8ZN): Ranked #1645 globally with a market cap of $14.97 Billion USD ( €12.81 Billion EUR).
- Walgreens Boots Alliance Inc (NASDAQ:WBA): Ranked #2214 globally with a market cap of $10.37 Billion USD.
- ALIB.HL.INF.TEC.UNSP.ADR (F:TWYA): Ranked #2563 globally with a market cap of $8.42 Billion USD ( €7.20 Billion EUR).
- Raia Drogasil S.A (SA:RADL3): Ranked #3217 globally with a market cap of $6.06 Billion USD ( R$30.90 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #1645 | JD HEALTH INTL LTD | F:8ZN | $14.97 Billion | €3.99 |
| #2214 | Walgreens Boots Alliance Inc | NASDAQ:WBA | $10.37 Billion | $11.98 |
| #2563 | ALIB.HL.INF.TEC.UNSP.ADR | F:TWYA | $8.42 Billion | €8.95 |
| #3217 | Raia Drogasil S.A | SA:RADL3 | $6.06 Billion | R$17.67 |
Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd Historical Marketcap From 2021 to 2026
Between 2021 and today, Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd's market cap moved from $676.38 Million to $ 285.54 Million, with a yearly change of -18.14%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥285.54 Million | -22.70% |
| 2025 | CN¥369.40 Million | +17.72% |
| 2024 | CN¥313.79 Million | -19.55% |
| 2023 | CN¥390.03 Million | -12.30% |
| 2022 | CN¥444.76 Million | -34.24% |
| 2021 | CN¥676.38 Million | -- |
End of Day Market Cap According to Different Sources
On Jun 17th, 2026 the market cap of Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $285.54 Million USD |
| MoneyControl | $285.54 Million USD |
| MarketWatch | $285.54 Million USD |
| marketcap.company | $285.54 Million USD |
| Reuters | $285.54 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Hunan Dajiaweikang Pharmaceutical Industry Co.Ltd
Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd engages in the wholesale and retail of pharmaceuticals products in China. It provides raw materials, biological products, chemical drugs, Chinese herbal medicines, medical devices, and other products. The company also offers Chinese patent medicines in the form of granules, capsules, particles, tablets, slices, and pills; foods, such as beverages… Read more